Introduction {#Sec1}
============

Due to urbanization, economic growth and an ageing population, China's disease spectrum has changed. Coronary heart disease (CHD) has become a public health issue and is the leading cause of death globally \[[@CR1], [@CR2]\]. CHD is not only an important cause of death in developed countries but also in developing countries \[[@CR3]\]. One of the treatment strategies for CHD is to relieve severe coronary occlusion, and another strategy is to control risk factors. Although percutaneous coronary intervention (PCI) has been an important technology for the treatment of CHD, it can only cause local vascular pathological changes \[[@CR4]\], and the entire atherosclerotic process should be considered. Therefore, postoperative management after PCI is essential.

Abnormal blood lipid metabolism is a risk factor for CHD \[[@CR5]\]. The increase in total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) and the decrease in high-density lipoprotein cholesterol (HDL-C) levels are the main factors associated with cardiovascular disease \[[@CR6]\]. Therefore, blood lipid levels play a crucial role in the development of CHD. Previous studies have shown that TC, LDL-C and triglyceride (TG) levels were increasing \[[@CR7], [@CR8]\], and hypercholesterolemia was not adequately controlled in Chinese adults aged 35 to 74 years \[[@CR7]\]. Meta-analysis results showed that an LDL-C reduction of 1 mmol/L can effectively reduce the incidence of cardiovascular events \[[@CR9]\].

Previous studies on dyslipidaemia have been conducted in individuals with chronic diseases such as hypertension and diabetes \[[@CR10]\], obese people \[[@CR11]\] and the Chinese general population \[[@CR7], [@CR12]--[@CR14]\]. There are relatively few studies on the management of dyslipidaemia in patients with PCI, and there are even fewer follow-up studies. The following hypothesis was proposed: Follow-up is helpful to control the lipid profiles in PCI patients. Therefore, this study aimed to explore the blood lipid status of patients after PCI through a one-year follow-up period.

Materials and methods {#Sec2}
=====================

Subjects {#Sec3}
--------

This retrospective analysis of 522 patients diagnosed with CHD (including acute myocardial infarction and unstable angina) successfully underwent stent implantation in acute or elective PCI in the cardiology department of one general hospital in Guangzhou from June 2015 to December 2017.
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Study procedure {#Sec4}
---------------

This study was conducted by a case manager. Because it is typical for patients who undergo PCI to stay in the cardiac intensive care unit (CCU) for one night, health education (focused on medication guidance, lifestyle, and follow up) for patients was first conducted by CCU nurses, and then the next day upon transfer to the general ward, the nurses in the general ward continued providing education to the patients. The case manager registered the patients' information and created a follow-up form. For the patients included in 2015 and 2016, the case manager followed up the patients discharged from the hospital after 1 year by telephone, gathering data including information on chest pain, medicine, follow-up, lifestyle, cardiac function. For patients in 2017, telephone follow-up was performed at 1 month, 3 months, 6 months and 1 year after discharge, and data were collected including information on medication, discomfort, complications, follow-up, lipids, colour Doppler sonography results and lifestyle. Patients in 2015 and 2016 were verbally informed about the follow-up procedure. Patients in 2017 were informed about a follow-up plan after which they provided written informed consent. To control the bias, the case manager was responsible for the whole process of recording the information in the database and the follow-up plan.

Study parameters {#Sec5}
----------------

The data were collected from medical records and face-to-face or telephone interviews. The information included demographic characteristics (name, gender, age, ethnicity, telephone number, residence, education, marital status, occupation, family monthly income), medical history (hypertension, diabetes, CHD, stroke and dyslipidaemia), lifestyle and self-management (diet control, daily staple food intake, regular exercise, weekly exercise time, smoking and drinking history), physical examination (height, weight), and laboratory examination (blood lipids at baseline and follow-up). The lipids were obtained in the morning after an overnight fast. TC (enzymatic method), TG (enzymatic method), HDL-C (direct method), and LDL-C (direct method) levels were measured.

Definition {#Sec6}
----------

The 2016 Chinese Guidelines for the Management of Dyslipidaemia in Adults were used to classify TC, TG, LDL-C and HDL-C levels \[[@CR15]\]. The classification was based on the criteria in the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report (NCEP-ATP III) \[[@CR16]\]. The diagnostic criteria of diabetes mellitus (DM) were based on the 1999 WHO diagnostic criteria \[[@CR17]\]. DM was defined as fasting plasma glucose (FPG) ≥ 7.0 mmol/L, 2-h postprandial plasma glucose (2hPG) ≥ 11.1 mmol/L, or diabetic symptoms along with a random plasma glucose level ≥ 11.1 mmol/L. Hypertension was defined as systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg. High TC was defined as TC ≥ 6.22 mmol/L. High LDL-C was defined as LDL-C ≥ 4.14 mmol/L, low HDL-C was defined as HDL-C \< 1.04 mmol/L, and high TG were defined as ≥2.26 mmol/L. Based on the status of self-reported smoking and the definition of the global adult tobacco survey \[[@CR18]\], individuals were categorized into three groups: never, former and current smokers. Respondents were asked whether they had a drink over the past year. According to the adult weight standard published by the Ministry of Health of China, body mass index (BMI) \< 18.5 kg/m^2^ indicated low weight, 18.5 kg/m^2^ ≤ BMI \< 24 kg/m^2^ indicated normal weight, 24 kg/m^2^ ≤ BMI \< 28 kg/m^2^ indicated overweight and BMI ≥ 28 kg/m^2^ indicated obesity. Light physical activity referred to sitting, standing or walking, and activities not requiring special muscular function, such as reading, writing, performing office work, assembling and repairing machines, lecturing, performing general laboratory operations, doing housework. Moderate physical activity referred to activities with greater muscular requirements, such as performing daily activities of students, driving motor vehicles, installing electrical components, cutting metal, performing woodworking operations. Heavy physical activity referred to nonmechanized agricultural labour, steelmaking, lathe operation, sports activities (swimming, mountain climbing, football). Regular exercise was defined as exercising at least 3 times a week for at least 30 mins at a time.

Data analysis {#Sec7}
-------------

All data were analysed using SPSS version 13.0 software. Quantitative data were expressed as the means ± SD. Categorical variables were estimated as frequencies. The comparisons of quantitative data were conducted using the independent samples *t*-test, and categorical variables were compared using the chi-square test. The comparison between lipid profiles at baseline and follow-up was performed using a paired t test. Binary logistic regression analysis was used to assess the risk factors. Odds ratios (ORs) with 95% confidence intervals (95%CIs) were expressed. *P* \< 0.05 was considered statistically significant.

Results {#Sec8}
=======

Demographic and clinical features of patients {#Sec9}
---------------------------------------------

Figure [1](#Fig1){ref-type="fig"} shows the flowchart of participants analysed in the study. A total of 522 patients aged 28--88 years (63.15 ± 11.38 years), including 393 males (75.3%) and 129 females (24.7%), were enrolled in the study. According to the LDL-C levels at baseline, patients were divided into five groups: \< 2.59 mmol/L, 2.59 mmol/L − \< 3.37 mmol/L, 3.37 mmol/L − \< 4.14 mmol/L, 4.14 mmol/L − \< 4.92 mmol/L, and ≥ 4.92 mmol/L. The differences in age, gender, BMI, education, residence, smoking, alcohol consumption, occupation, family monthly income, diet control, daily staple food intake and physical activity were not significant (*P* \> 0.05) (Table [1](#Tab1){ref-type="table"}). In addition, patients were divided into three groups separately based on TC, TG and HDL-C levels at baseline. The differences in TG levels at baseline according to age, BMI, education, drinking and daily staple food intake were significant (*P* \< 0.05). Gender, BMI, smoking and alcohol consumption were significantly associated with HDL-C levels at baseline (*P* \< 0.05) (Table [2](#Tab2){ref-type="table"}). Fig. 1Flow diagram of patients analysed in the studyTable 1Characteristics of the patients according to the LDL levels at baselineCharacteristicsLDL-C levels\< 2.592.59- \< 3.373.37- \< 4.144.14- \< 4.92≥4.92χ^2^*P*-valueAge (years), n(%)29.7930.073 28--290 (0.0)0 (0.0)1 (100.0)0 (0.0)0 (0.0) 30--395 (38.5)4 (30.8)2 (15.4)2 (15.4)0 (0.0) 40--4914 (29.2)9 (18.8)18 (37.5)5 (10.4)2 (4.2) 50--5941 (30.4)42 (31.1)39 (28.9)9 (6.7)4 (3.0) 60--6971 (44.7)39 (24.5)31 (19.5)16 (10.1)2 (1.3)  ≥ 70(%)76 (45.8)48 (28.9)25 (15.1)12 (7.2)5 (3.0)Gender, n(%)0.6370.959 Male156 (39.7)108 (27.5)88 (22.4)31 (7.9)10 (2.5) Female51 (39.5)34 (26.4)28 (21.7)13 (10.1)3 (2.3)BMI (kg/m^2^), n(%)11.5430.483  \< 18.54 (36.4)3 (27.3)3 (27.3)0 (0.0)1 (9.1) 18.5- \< 24.0110 (41.5)75 (28.3)53 (20.0)23 (8.7)4 (1.5) 24.0- \< 28.068 (38.0)50 (27.9)38 (21.2)16 (8.9)7 (3.9)  ≥ 28.025 (37.3)14 (20.9)22 (32.8)5 (7.9)1 (1.5)Education, n(%)5.0060.958 Primary school32 (42.7)19 (25.3)15 (20.0)7 (9.3)2 (2.7) Middle school82 (38.5)58 (27.2)51 (23.9)16 (7.5)6 (2.8) High school81 (40.1)53 (26.2)43 (21.3)20 (9.9)5 (2.5)  \> High school12 (37.5)12 (37.5)7 (21.9)1 (3.1)0 (0.0)Residence, n(%)0.2670.992 Urban132 (40.4)88 (26.9)71 (21.7)28 (8.6)8 (2.4) Rural75 (38.5)54 (27.7)45 (23.1)16 (8.2)5 (2.6)Smoking, n(%)12.0970.147 Never131 (43.2)78 (25.7)65 (21.5)22 (7.3)7 (2.3) Former22 (50.0)11 (25.0)6 (13.6)3 (6.8)2 (4.5) Current54 (31.0)53 (30.5)45 (25.9)19 (10.9)3 (1.7)Drinking, n(%)4.5530.336 Yes23 (39.0)11 (18.6)16 (27.1)6 (10.2)3 (5.1) No184 (39.7)131 (28.3)100 (21.6)38 (8.2)10 (2.2)Occupation, n(%)12.7190.122 Light179 (41.7)115 (26.8)93 (21.7)31 (7.2)11 (2.6) Medium27 (30.3)24 (27.0)23 (25.8)13 (14.6)2 (2.2) others1 (25.0)3 (75.0)0 (0.0)0 (0.0)0 (0.0)Famliy monthly income per capita, n(%)9.9870.617  \< 10000 (0.0)0 (0.0)1 (100.0)0 (0.0)0 (0.0) 1000--300058 (37.2)41 (26.3)40 (25.6)13 (8.3)4 (2.6) 3000--6000135 (41.7)85 (26.2)68 (21.0)29 (9.0)7 (2.2)  \> 600014 (34.1)16 (39.0)7 (17.1)2 (4.9)2 (4.9)Diet control, n(%)5.9480.203 No39 (31.7)33 (26.8)34 (27.6)13 (10.6)4 (3.3) Yes168 (42.1)109 (27.3)82 (20.6)31 (7.8)9 (2.3)Daily staple food intake, n(%)12.3080.138 Rice185 (38.8)128 (26.8)112 (23.5)40 (8.4)12 (2.5) Noodle1 (14.3)3 (42.9)1 (14.3)2 (28.6)0 (0.0) Rice+Noodle21 (55.3)11 (28.9)3 (7.9)2 (5.3)1 (2.6)Physical activity, n(%)6.3490.175 No5 (20.0)8 (32.0)8 (32.0)4 (16.0)0 (0.0) Yes202 (40.6)134 (27.0)108 (21.7)40 (8.0)13 (2.6)*LDL-C* low-density lipoprotein cholesterol, *BMI* body mass indexTable 2Characteristics of the patients according to the other lipid profiles levels at baselineCharacteristicsTC levelsχ^2^*P*TG levelsχ^2^*P*HDL-C levelsχ^2^*P*\< 5.185.18- \< 6.22≥6.22\< 1.691.69- \< 2.26≥2.26\< 1.041.04- \< 1.55≥1.55Age (years), n(%)10.6660.38427.7590.00212.4500.256 28--291 (100)0 (0.0)0 (0.0)0(0.0)0(0.0)1(100.0)1(100.0)0(0.0)0(0.0) 30--397 (53.8)4 (30.8)2 (15.4)3(23.1)3(23.1)7(53.8)9(69.2)4(30.8)0(0.0) 40--4925 (52.1)16 (33.3)7 (14.6)25(52.1)8(16.7)15(31.1)29(60.4)18(37.5)1(2.1) 50--5984 (62.2)39 (28.9)12 (8.9)71(52.6)26(19.3)38(28.1)87(64.4)43(31.9)5(3.7) 60--69107(67.3)32 (20.1)20 (12.6)100(62.9)29(18.2)30(18.9)92(57.9)61(38.4)6(3.8)  ≥ 70113(68.1)31 (18.7)22 (13.3)116(69.9)27(16.3)23(13.9)79(47.6)76(45.8)11(6.6)Gender, n(%)5.2390.0730.0730.96420.184\< 0.001 Male264(67.2)87(22.1)42(10.7)238(60.6)69(17.6)86(21.9)244(62.1)137(34.9)12(3.1) Female73 (56.6)35(27.1)21(16.3)77(59.7)24(18.6)28(21.7)53(41.1)65(50.4)11(8.5)BMI (kg/m^2^), n(%)1.7480.94119.7920.00322.7860.001  \< 18.57(63.6)3(27.3)1(9.1)10(90.9)0(0.0)1(9.1)2(18.2)6(54.5)3(27.3) 18.5- \< 24.0176(66.4)61(23.0)28(10.6)171(64.5)51(19.2)43(16.2)152(57.4)104(39.2)9(3.4) 24.0- \< 28.0113(63.1)41(22.9)25(14.0)104(58.1)29(26.2)46(25.7)112(62.6)60(33.5)7(3.9)  ≥ 28.041(61.2)17(25.4)9(13.4)30(44.8)13(19.4)24(35.8)31(46.3)32(47.8)4(6.0)Education, n(%)5.4510.48713.3400.0389.6850.139 Primary school46(61.3)17(22.7)12(16.0)56(74.7)7(9.3)12(16.0)31(41.3)39(52.0)5(6.7) Middle school134(62.9)55(25.8)24(11.3)128(60.1)39(18.3)46(21.6)124(58.2)80(37.6)9(4.2) High school135(66.8)41(20.3)26(12.9)110(54.5)39(19.3)53(26.2)124(61.4)71(35.1)7(3.5)  \> High school22(68.8)9(28.1)1(3.1)21(65.6)8(25.0)3(9.4)18(56.3)12(37.5)2(6.3)Residence, n(%)4.4070.3545.5840.2320.9450.918 Urban211(64.5)73(22.3)43(13.1)200(61.2)62(19.0)65(19.9)184(56.3)129(39.4)14(4.3) Rural126(64.9)48(24.7)20(10.3)115(59.3)31(16.0)48(24.7)112(57.7)73(37.6)9(4.6)Smoking, n(%)0.4590.9777.1170.13025.007\< 0.001 Never196(64.7)70(23.1)37(12.2)195(64.4)50(16.5)58(19.1)148(48.8)142(46.9)13(4.3) Former27(61.4)12(27.3)5(11.4)28(63.6)7(15.9)9(20.5)26(59.1)14(31.8)4(9.1) Current114(65.5)40(23.0)20(11.5)91(52.3)36(20.7)47(27.0)123(70.7)46(26.4)5(2.9)Drinking, n(%)0.1740.9177.3880.0258.0110.018 Yes38(64.4)13(22.0)8(13.6)29(49.2)9(15.3)21(35.6)42(71.2)13(22.0)4(6.8) No299(64.6)109(23.5)55,911.9)286(61.8)84(18.1)91(20.1)255(55.1)189(40.8)19(4.1)Occupation, n(%)3.8140.4321.9080.7531.7720.778 Light284(66.2)95(22.1)50(11.7)257(59.9)79(18.4)93(21.7)245(57.1)163(38.0)21(4.9) Medium50(56.2)26(29.2)13(14.6)55(61.8)13(14.6)21(23.6)50(56.2)37(41.6)2(2.2) others3(15.0)1(25.0)0(0.0)3(75.0)1(25.0)0(0.0)2(50.0)2(50.0)0(0.0)Famliy monthly income per capita, n(%)8.7570.18810.8150.0945.3590.499  \< 10000(0.0)1(100.0)0(0.0)1(100.0)0(0.0)0(0.0)0(0.0)1(100.0)0(0.0) 1000--300098(62.8)44(28.2)14(9.0)99(63.5)20((12.8)37(23.7)86(55.1)60(38.5)10(6.4) 3000--6000213(65.7)66(20.4)45(13.9)191(59.0)60(18.5)73(22.5)189(58.3)125(38.6)10(3.1)  \> 600026(63.4)11(26.8)4(9.8)24(58.5)13(31.7)4(9.8)22(53.7)16(39.0)3(7.3)Diet control, n(%)5.0860.0791.6500.4384.9760.083 No69(56.1)35(28.5)19(15.4)70(56.9)21(17.1)32(26.0)60(48.8)55(44.7)8(6.5) Yes268(67.2)87(21.8)44(11.0)245(61.4)72(18.0)82(20.6)237(59.4)147(36.8)15(3.8)Daily staple food intake, n(%)3.6450.4569.8220.0448.8380.065 Rice306(64.2)113(23.7)58(12.2)281(58.9)90(18.9)106(22.2)280(58.7)178(37.3)19(4.0) Noodle3(42.9)2(28.6)2(28.6)3(42.9)1(14.3)3(42.9)2(28.6)4(57.1)1(14.3) Rice + Noodle28(73.7)7(18.4)3(7.9)31(81.6)2(5.3)5(13.2)15(39.5)20(52.6)3(7.9)Physical activity, n(%)1.5810.4540.2090.9010.0250.988 No15(60.0)5(20.0)5(20.0)14(56.0)5(20.0)6(24.0)14(56.0)10(40.0)1(4.0) Yes322(64.8)117(23.5)58(11.7)301(60.6)88(17.7)108(21.7)283(56.9)192(38.6)22(4.4*TC* total cholesterol, *TG* triglyceride, *LDL-C* low-density lipoprotein cholesterol, *HDL-C* high-density lipoprotein cholesterol, *BMI* body mass index

The mean values of TC, TG, LDL-C, and HDL-C at baseline were 4.76, 1.80, 2.93 and 1.03 mmol/L, respectively. After 1 year of follow-up, the mean TC, TG, LDL-C, and HDL-C levels were 3.94, 1.62, 2.26 and 1.01 mmol/L, respectively. There was a significant difference in TC, TG and LDL-C levels between baseline and follow-up (*P* \< 0.05) (Table [3](#Tab3){ref-type="table"}). The prevalence of high TC, high TG, high LDL-C and low HDL-C at baseline was 12.05, 21.80, 10.90 and 56.79%, respectively, and the prevalence at follow-up was 4.59, 15.68, 3.25 and 59.85%, respectively. The difference in prevalence between baseline and follow-up was significant (*P* \< 0.05) (Table [4](#Tab4){ref-type="table"}). Table 3The comparison of lipid profiles between baseline and follow-upCharacteristicsAt baselineAt follow-upt*P*TC4.76 ± 1.253.94 ± 1.0511.456\< 0.001TG1.80 ± 1.311.62 ± 1.252.2560.024LDL-C2.93 ± 0.942.26 ± 0.8112.428\< 0.001HDL-C1.03 ± 0.281.01 ± 0.281.0820.279*TC* total cholesterol, *TG* triglyceride, *LDL-C* low-density lipoprotein cholesterol, *HDL-C* high-density lipoprotein cholesterolTable 4The comparison of high lipid prevalence between baseline and follow-upCharacteristicsPrevalence (%)χ^2^*P*At baselineAt follow-upHigh TC12.054.5919.072\< 0.001High TG21.8015.686.4320.011High LDL-C10.903.2523.271\< 0.001Low HDL-C56.7959.851.2200.269*TC* total cholesterol, *TG* triglyceride, *LDL-C* low-density lipoprotein cholesterol, *HDL-C* high-density lipoprotein cholesterol

Among 522 patients included in the 1 year follow-up, a total of 484 patients' stents were unobstructed, 1 had reimplantation via PCI, 7 had intimal hyperplasia, 1 died, 7 had stent stenosis, 22 were followed up for blood lipids in the outpatient department, and no patients were hospitalized for vascular examination.

As shown in Table [5](#Tab5){ref-type="table"}, the proportion of patients at follow-up with borderline high (5.18 − \< 6.22 mmol/L) and high TC levels (≥ 6.22 mmol/L) was 7.1 and 4.6%, respectively, which was higher among those living in rural areas than urban areas. The proportion of patients at follow-up with borderline high (1.69 − \< 2.26 mmol/L) and high (≥2.26 mmol/L) TG was 15.7 and 15.7%, respectively, and the proportion was higher in younger patients than in older patients. The proportion of patients at follow-up with low HDL-C was 60.2%, which was much higher in younger patients than in older patients and was higher in men than in women. The proportion of patients at follow-up with borderline high (3.37 − \< 4.14 mmol/L), high (4.14 − \< 4.92 mmol/L), and very high (≥ 4.92 mmol/L) LDL-C levels was 6.1, 2.1 and 1.1%, respectively. The proportion of patients living in rural areas with borderline high, high and very high LDL-C was significantly higher than that of patients living in urban areas. Table 5Proportion of lipid fraction serum levels at follow-up according to Chinese guidelines classificationOverallAgeGenderResidence28--4950--69≥70*P*-valueMenWomen*P*-valueUrbanRural*P*-valueTC, mmol/L0.2720.1360.063 Desirable\< 5.1888.387.187.490.489.186.090.584.6 Borderline high5.18- \< 6.227.14.88.84.87.46.26.48.2 High≥6.224.68.13.74.83.67.83.17.2TG, mmol/L\< 0.0010.8160.235 Desirable\< 1.6968.646.868.077.768.269.871.364.1 Borderline high1.69- \< 2.2615.721.017.710.216.314.014.417.9 High≥2.2615.732.314,312.015.516.314.417.9HDL-C, mmol/L0.007\< 0.0010.857 Low\< 1.0460.279.059.254.866.740.360.659.5 Desirable1.04- \< 1.5535.221.036.738.030.051.234.636.4 High≥1.554.60.04.17.23.38.54.94.1LDL-C, mmol/L0.2540.1830.021 Desirable\< 2.5973.462.974.175.974.370.575.869.2 Near or above optimal2.59- \< 3.3717.227.416.015.716.818.616.518.5 Borderline high3.37- \< 4.146.14.86.16.66.45.45.86.7 High4.14- \< 4.922.11.62.41.82.02.31.82.6 Very high≥4,921.13.21.40.00.53.10.03.1*TC* total cholesterol, *TG* triglyceride, *LDL-C* low-density lipoprotein cholesterol, *HDL-C* high-density lipoprotein cholesterol

Multivariate logistic regression analysis showed that gender was risk factor for high TC (≥ 6.22 mmol/L), low HDL-C (\< 1.04 mmol/L) and high LDL-C (≥ 4.14 mmol/L) at follow-up. Age was the factor associated with high TG (≥ 2.26 mmol/L) and low HDL-C (\< 1.04 mmol/L) at follow-up. Besides, smoking and diet control were risk factors for low HDL-C (\< 1.04 mmol/L) and high LDL-C (≥ 4.14 mmol/L) at follow-up, respectively (Table [6](#Tab6){ref-type="table"}). Table 6The association between factors at baseline and dyslipidemia at follow-up in a binary logistic regression analysesTC ≥ 6.22 mmol/LTG ≥ 2.26 mmol/LHDL-C \< 1.04 mmol/LLDL-C ≥ 4.14 mmol/LOR95%*CIP* valueOR95%*CIP* valueOR95%*CIP* valueOR95%*CIP* valueGender0.2680.082,0.8750.0290.9150.471,1.7770.7932.7541.679,4.517\< 0.0010.1530.034,0.6870.014Age1.0080.964,1.0540.7341.0301.005,1.0550.0201.0251.005,1.0450.0141.0300.978,1.0860.261BMI1.0110.868,1.1770.8891.0050.921,1.0970.9061.0350.968,1.1070.3181.1960.989,1.4460.064Education1.0420.485,2.2360.9171.0320.670,1.5890.8861.3760.994,1.9060.0540.5940.238,1.4840.265Residence0.5220.195,1.3990.1960.8140.464,1.4270.4721.1970.766,1.8700.4290.3520.107,1.1560.085Smoking0.6900.387,1.2290.2081.1540.857,1.5540.3460.7900.626,0.9980.0480.8060.389,1.6720.563Drinking1.6270.464,5.7020.4471.6220.784,3.3550.1920.7740.416,1.4410.4193.6430.945,14.0390.060Occupation1.1150.373,3.3280.8451.4690.740,2.9170.2720.9210.587,1.4460.7211.2600.348,4.5640.725Famliy monthly income per capita1.2110.474,3.0900.6891.1660.680,1.9990.5780.7570.497,1.1510.1931.0090.347,2.9350.987Diet control1.4890.506,4.3820.4701.2770.667,2.4470.4601.0480.627,1.7520.8574.4641.265,15.7500.020Daily staple food intake2.3410.514,10.6690.2721.3290.715,2.4690.3680.9870.669,1.4540.946///Physical activity1.6940.328,8.7580.5300.7370.205,2.6510.6401.9350.728,5.1390.1862.9940.508,17.6390.226*TC* total cholesterol, *TG* triglyceride, *LDL-C* low-density lipoprotein cholesterol, *HDL-C* high-density lipoprotein cholesterol, *BMI* body mass index

Discussion {#Sec10}
==========

Blood lipid management after PCI is essential because dyslipidaemia is an important risk factor for CHD. This study was performed by recruiting 522 patients from 2015 to 2017 who had undergone PCI. The results showed that a significant decrease in the mean TC, TG and LDL-C levels was observed between baseline and follow-up. Similarly, a significant decrease in the prevalence of high TC, high TG and high LDL-C was observed over the same period. The mean TC, TG, LDL-C, and HDL-C levels at baseline were 4.76, 1.80, 2.93, and 1.03 mmol/L, respectively, which were higher than the mean values of lipids in Chinese adults reported in the 1983, 1993 \[[@CR13]\], 2013--2014 \[[@CR12]\], and 2002 China National Nutrition and Health Survey \[[@CR14]\], respectively. This may be related to the information on myocardial infarction reported in this study. The TC and LDL-C levels were significantly lower in this study than the levels in the United States \[[@CR19]\] and Japan \[[@CR20]\] but similar to those in Korea \[[@CR21]\]. After 1 year of follow-up, the patients' TC, TG, LDL-C and HDL-C levels were significantly lower than those at baseline, which indicates that post-discharge follow-up management is essential.

The current study confirmed that the prevalence rates of high TC, high TG, high LDL-C and low HDL-C at baseline were 12.05, 21.80, 10.90, and 56.79%, respectively, which were higher than those reported in 2002 \[[@CR14]\] and 2013--2014 \[[@CR12]\]. This was mainly due to the different populations involved and the different definitions of the indicators. Dyslipidaemia in this population is mainly reflected by lower HDL-C and higher TG, which is consistent with findings in previous studies \[[@CR12]\] but different from those in the United States (high TC and high LDL-C) \[[@CR19]\], which may be due to differences in diet and genetic susceptibility.

The study suggested that age was the factor associated with high TG and low HDL-C at follow-up. Gender was risk factor for high TC, low HDL-C and high LDL-C at follow-up. Besides, smoking and diet control were risk factors for low HDL-C and high LDL-C at follow-up respectively. Previous studies reported that age appeared to influence dyslipidaemia risk \[[@CR7], [@CR22], [@CR23]\]. Similar results were found in this study. The reason for this may be poor compliance with long-term drug treatment, more comorbidities, high economic pressure, failure to buy drugs and difficulty in making lifestyle changes among elderly patients. The mechanism of the effect of age on lipids is not well known. Other research has observed an association between dyslipidaemia and gender \[[@CR7], [@CR22], [@CR23]\]. This study also showed that gender was related to high TC, low HDL-C and high LDL-C at follow-up. This may be associated with lifestyle and dietary differences.

A previous study revealed associations between dyslipidaemia and smoking \[[@CR24]\]. The results demonstrated that smoking was significantly associated with the risk of low HDL-C at follow-up. Nicotine, caffeine and other substances in tobacco can stimulate blood vessels and cause structural changes, which leads to dyslipidaemia. Moreover, the importance of diet control is evident for the control of blood lipid levels. Besides, due to the 100% or 99% would be positive, the daily staple food intake was not be included in the regression analysis when analyzing the LDL-C.

Study strengths and limitations {#Sec11}
-------------------------------

The major strength of the study was the inclusion of PCI patients, which provided a representativeness of the findings in PCI management. Standardized survey instruments and a trained interviewer guaranteed the reliability of the analyses. Some limitations of the study deserve to be mentioned. First, the patients included in 2015 and 2016 did not have a detailed follow-up plan, thus follow-up was performed only 1 year after discharge. Second, during the telephone follow-up period, the patients were only verbally asked if their lifestyle and habits had improved; therefore, there was a lack of data registration for changes in lifestyle at follow-up. Third, due to the lack of information on lifestyle changes, it was impossible to discuss the relationship between lipid profiles and lifestyle changes at follow-up. Fourth, although lipid-lowering medication data existed, the related lifestyle changes were not registered, thus the relationship between lipid profiles at follow-up and lipid-lowering medication could not analysed. Lastly, because of missing information, the comparison between participants who were followed up and participants who were not followed up were not analysed.

Conclusions {#Sec12}
===========

In conclusion, after 1 year of follow-up, the mean values of lipids and the prevalence of dyslipidaemia in patients with PCI at follow-up included in the study were significantly lower than those at baseline. Gender, age, smoking, and diet control affected patients' blood lipids. Therefore, postoperative management of discharged PCI patients is crucial and provides a basis for primary health care. However, a large sample size and long-term follow-up are needed to further explore the associations of lifestyle changes and medication with CHD, lipid profiles and end events.

CHD

:   Coronary heart disease

PCI

:   Percutaneous coronary intervention

TC

:   Total cholesterol

TG

:   Triglyceride

LDL-C

:   Low-density lipoprotein cholesterol

HDL-C

:   High-density lipoprotein cholesterol

CCU

:   Cardiac intensive care unit

NCEP

:   National Cholesterol Education Program

NCEP-ATP III

:   National Cholesterol Education Program (Adult Treatment Panel III)

DM

:   Diabetes mellitus

FPG

:   Fasting plasma glucose

2hPG

:   2 h postprandial plasma

SBP

:   Systolic blood pressure

DBP

:   Diastolic blood pressure

BMI

:   Body mass index

OR

:   Odds ratios
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